胰岛细胞与骨髓间充质干细胞联合移植治疗糖尿病的进展  

The progress of islet cells co-transplantation with bone marrow mesenchymal stem cells in the treatment of diabetes

作　　者：施静[1,2] 姚豫桐 冯天航[3] 魏玲玲 赖春友[1] 邓绍平 黄孝伦[1] SHI Jing;YAO Yutong;FENG Tianhang;WEI Lingling;LAI Chunyou;DENG Shaoping;HUANG Xiaolun(Cell Transplantation Center, Affiliated Hospital of University of Electronic Science and Technology of China, Sichuan Provincial People＇s Hospital, Chengdu 610072, P. R. China;Molecular Medicine Laboratory, Hospital of Chengdu Office of People＇s Government of Tibetan Autonomous Region, Chengdu 610041, P. R. China;Zunyi Medical University, Zunyi, Guizhou 563003, P. R. China)

机构地区：[1]电子科技大学附属医院.四川省人民医院细胞移植中心,成都610072 [2]西藏自治区人民政府驻成都办事处医院分子医学实验室,成都610041 [3]遵义医学院,贵州遵义563003

出　　处：《中国普外基础与临床杂志》2018年第5期635-638,共4页Chinese Journal of Bases and Clinics In General Surgery

摘　　要：目的总结胰岛细胞与骨髓间充质干细胞联合移植治疗糖尿病的可行性与安全性。方法收集国内外有关胰岛细胞与骨髓间充质干细胞移植治疗糖尿病的文献并作综述。结果目前糖尿病的治疗方法主要为胰腺移植和胰岛细胞移植,其中胰腺移植的手术创伤大、死亡率高;胰岛细胞移植虽安全性较高,但排斥反应强,胰岛细胞在体内的长期存活时间不理想,严重影响其远期疗效。骨髓间充质干细胞与胰岛细胞联合移植能缓解排斥反应,延长胰岛细胞的存活时间,可以更有效地治疗糖尿病。结论胰岛细胞与骨髓间充质干细胞联合移植具有降低排斥反应、减轻炎症反应、延长胰岛细胞的存活时间及延长降血糖时间的效果,可能是新的治疗糖尿病的手段。Objective To summarize the feasibility and safety of the islet cells co-transplantation with bone marrow mesenchymal stem cells （BMSCs） in the treatment of diabetes. Methods The latest progress and new achievements of islet cells transplantation and BMSCs transplantation in treatment of diabetes in the world were analyzed and reviewed. Results At present, the pancreas transplantation and the islet cells transplantation were mainly treatments for diabetes, the pancreas transplantation had disadvantages of large trauma and high mortality; the islet cells transplantation was safe, but had disadvantages of strong rejection, and the survival time of islets cells were short which affected the treatment effect of diabetes. The BMSCs co-transplanted with the islet cells could prolong the survival time of islet cells and could alleviate the rejection in body, so the co-transplantation can be more effective in treatment of diabetes. Conclusion The BMSCs co-transplant with the islet cells could reduce the rejection in vivo, reduce the inflammation in vivo, prolong the survival time of islet cells, extend the time of normal glucose, which may become the new treatment method for the diabetes.

关 键 词：糖尿病 胰岛细胞移植 骨髓间充质干细胞 综述 

分 类 号：R587.1[医药卫生—内分泌]